Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 2. MSC Activation. After there is tissue damage, different proinflammatory cytokines produced by lymphocytes can “activate” MSC to start producing anti-inflammatory factors like indoleamine 2,3-dioxygenase, prostaglandin E2, nitric oxide, interleukin 10. Pathogen-associated molecular patterns (PAMPS) and Damage-associated molecular patterns (DAMPS) can also activate MSC by ligating with toll-like-receptors on the surface of MSC. Depending on species, different TLR ligation can commit MSC to express either a pro-inflammatory phenotype (MSC1) which secretes proinflammatory cytokines like interleukin 6, interleukin-8, transforming growth factor beta, or an anti-inflammatory phenotype (MSC2).
Biomolecules & Therapeutics 2019;27:25~33 https://doi.org/10.4062/biomolther.2017.260
© Biomolecules & Therapeutics